Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000151

Chief Executive Officer sold 200,000 shares at an average $45.44 ($9,088,499)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Congleton Jon Chief Executive Officer 2025-11-11 Sale −12,806 $41.64 $533,235 818,499 D
Congleton Jon Chief Executive Officer 2025-11-11 Sale −8,862 $42.31 $374,947 809,637 D
Congleton Jon Chief Executive Officer 2025-11-11 Sale −4,000 $43.50 $173,984 805,637 D
Congleton Jon Chief Executive Officer 2025-11-11 Sale −29,207 $45.20 $1,320,165 776,430 D
Congleton Jon Chief Executive Officer 2025-11-11 Sale −112,275 $45.83 $5,145,956 664,155 D
Congleton Jon Chief Executive Officer 2025-11-11 Sale −32,850 $46.89 $1,540,212 631,305 D
Open-market sales · 200,000 sh · avg $45.44 · $9,088,499
Loading xslF345X05/wk-form4_1763078487.xml…